Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Hahn

Showing results (261-270 of 368) with videos related to

Pageof 37
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagusJ D Earle, R D Gelber, C G Moertel, et al.
Cancer Research|June 1, 1972
A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|August 1, 1972
Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancerC G Moertel, R J Reitemeier, A J Schutt, et al.
American Journal of Obstetrics and Gynecology|July 15, 1973
Pilot study evaluating 1,3-bis(2-chloroethyl)-1-nitrosourea in the treatment of advanced ovarian carcinomaE O Jorgensen, G D Malkasian, M J Webb, et al.
Cancer Chemotherapy Reports|December 1, 1970
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinomaC G Moertel, R J Reitemeier, R G Hahn, et al.
Cancer Chemotherapy Reports|November 1, 1974
100% oxygen inhalation and 5-fluorouracil (NSC-19893) therapy for large bowel carcinomaC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer|April 1, 1975
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinomaR G Hahn, C G Moertel, A J Schutt, et al.
Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.
The Journal of Family Practice|February 1, 1992
Obstetric ultrasound by family physiciansW M Rodney, M E Deutchman, K J Hartman, et al.
Cancer Chemotherapy Reports|June 1, 1972
Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancerD L Ahmann, D T Carr, D T Coles, et al.
Pageof 37

Showing results (261-270 of 368) with videos related to

Sort By:
Pageof 37
International Journal of Radiation Oncology, Biology, Physics|July 1, 1980
A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagusJ D Earle, R D Gelber, C G Moertel, et al.
Cancer Research|June 1, 1972
A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancerC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer Chemotherapy Reports|August 1, 1972
Effect of resection of the primary neoplasm on responsiveness to chemotherapy of patients with large bowel cancerC G Moertel, R J Reitemeier, A J Schutt, et al.
American Journal of Obstetrics and Gynecology|July 15, 1973
Pilot study evaluating 1,3-bis(2-chloroethyl)-1-nitrosourea in the treatment of advanced ovarian carcinomaE O Jorgensen, G D Malkasian, M J Webb, et al.
Cancer Chemotherapy Reports|December 1, 1970
5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinomaC G Moertel, R J Reitemeier, R G Hahn, et al.
Cancer Chemotherapy Reports|November 1, 1974
100% oxygen inhalation and 5-fluorouracil (NSC-19893) therapy for large bowel carcinomaC G Moertel, A J Schutt, R J Reitemeier, et al.
Cancer|April 1, 1975
A double-blind comparison of intensive course 5-flourouracil by oral vs. intravenous route in the treatment of colorectal carcinomaR G Hahn, C G Moertel, A J Schutt, et al.
Journal of the National Cancer Institute|January 1, 1976
Phase I study of a five-day intermittent schedule for 1,2:5,6-dianhydrogalactitol (NSC-132313)R T Eagan, C G Moertel, R G Hahn, et al.
The Journal of Family Practice|February 1, 1992
Obstetric ultrasound by family physiciansW M Rodney, M E Deutchman, K J Hartman, et al.
Cancer Chemotherapy Reports|June 1, 1972
Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancerD L Ahmann, D T Carr, D T Coles, et al.
Pageof 37